Report for Q1 2026
Filed with SSE · · 11 pages · Chinese
Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix
Earlier from Shanghai Shyndec Pharmaceutical
- Announcement on Progress in Providing Guarantees for Subsidiaries
- Earnings Preannouncement for Q1 2026
- Announcement on Voluntary Information Disclosure of Wholly-owned Subsidiary's Drug Passing Consistency Evaluation for Generic Drugs
- Announcement on Estimated Daily Related Party Transactions in 2026
- by Holding Subsidiary
Later from Shanghai Shyndec Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Wholly-owned Subsidiary's Drug Substance Obtaining Indian Registration Certificate
- Announcement on Obtaining Drug Registration Certificate
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Obtaining Drug Registration Certificate by Subsidiary
Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Shyndec Pharmaceutical